Abstract
The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Protein & Peptide Letters
Title:Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders
Volume: 25 Issue: 7
Author(s): Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam and Mohammad Amjad Kamal*
Affiliation:
- Novel Global Community Educational Foundation, Sydney,Australia
Abstract: The paper by Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam, Mohammad Amjad Kamal entitled “Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders” is being retracted from the Protein & Peptide Letters, Volume 25, Issue 7, due to the use of Figure from an earlier publication without permission or attribution. In addition, some text was copied and used in the paper without quotation marks or proper citation.
Export Options
About this article
Cite this article as:
Niazi Rasul Zahid , Khan Naqab , Khan Samiullah , Alam Mehboob and Kamal Amjad Mohammad *, Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders, Protein & Peptide Letters 2018; 25 (7) . https://dx.doi.org/10.2174/0929866525666180614120407
DOI https://dx.doi.org/10.2174/0929866525666180614120407 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Brain Magnetic Stimulation in Animal Models: A Valuable Lesson for Clinical Applications
CNS & Neurological Disorders - Drug Targets Synthesis, Experimental and Computational Studies of N-(4-amino-6-oxo- 1,6-dihydropyrimidin-5-yl)benzamide
Letters in Organic Chemistry Comparison of Status Epilepticus Models Induced by Pilocarpine and Nerve Agents - A Systematic Review of the Underlying Aetiology and Adopted Therapeutic Approaches
Current Medicinal Chemistry Therapeutic Potential of Natural Products from Terrestrial Plants as TNF-α Antagonist
Current Topics in Medicinal Chemistry Current and Promising Pharmacotherapies, and Novel Research Target Areas in the Treatment of Alcohol Dependence: A Review
Current Pharmaceutical Design Clinical, Immunological and Therapeutic Aspects of Autoimmune Encephalitis
Recent Patents on CNS Drug Discovery (Discontinued) Effects of Obesity on Vascular Potassium Channels
Current Vascular Pharmacology The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
Current Neuropharmacology Synthesis and Analysis of Anticonvulsant Activities of New 4-[2-(4- alkoxybenzylamino)ethyl]-2H-1,2,4-triazol-3(4H)-one Derivatives
Letters in Drug Design & Discovery Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo
CNS & Neurological Disorders - Drug Targets Genetics and Mitochondrial Abnormalities in Autism Spectrum Disorders:A Review
Current Genomics Medicinal Chemistry of Antimigraine Drugs
Current Medicinal Chemistry Preface [Hot topic: Carbohydrates (Executive Editor: Istvan Toth)]
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 9
Current Medicinal Chemistry Activators and Inhibitors of the Ion Channel of the NMDA Receptor
Current Drug Targets Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?
CNS & Neurological Disorders - Drug Targets Homocysteine and Folate Therapy in Dialysis Patients
Letters in Drug Design & Discovery Aldehyde Dehydrogenase as a Marker for Stem Cells
Current Stem Cell Research & Therapy Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction
Current Drug Targets